Actively Recruiting
Case-Finding for Neurocognitive Disorders in Pavia
Led by IRCCS National Neurological Institute "C. Mondino" Foundation · Updated on 2025-05-21
490
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Dementia is a global public health challenge with a heavy caregiving burden, impacting families, communities, and healthcare systems. It is a priority in healthcare planning, with focus on early diagnosis and ongoing support. This research project addresses the global public health challenge posed by dementia, focusing on early detection and comprehensive care. The research evaluates the clinical, social, and healthcare impact of two dementia-related projects in Italy: 1. the first "Ricor-Dare," aims to create an integrated network for identifying new cases of dementia or Mild Cognitive Impairment (MCI) and providing care to patients and caregivers; 2. the second involves establishing a new Center for Cognitive Disorders and Dementia (CCDD) in an area previously lacking such services. The primary goal of this study is to assess the effectiveness of case-finding strategies promoted by the "Ricor-Dare" project for the early detection of cognitive decline. Researchers will compare three different settings in which case-finding will be conducted: at the general practitioners' offices, at the Dementia Operations Center, and at Open Days for the general population. The aim is to measure how many individuals in these three settings are diagnosed with Mild Cognitive Impairment (MCI) or dementia, compared to those identified as potential cases through cognitive testing. The secondary goal of the study is to assess the social, care, and prevention impact of the activities offered within the two projects. This includes evaluating the experiences of patients and families who access the new CCDD in the province of Pavia, the impact of care pathways on caregivers, and comparing the effectiveness of the new CCDD with existing ones in the region of Lombardia. The study will also assess the role of the "Ricor-Dare" project in addressing the needs of patients, caregivers, and professionals, as well as the effectiveness of awareness-raising and training activities on dementia. Overall, the study aims to provide valuable insights into improving care for people with dementia and supporting their families and caregivers.
CONDITIONS
Official Title
Case-Finding for Neurocognitive Disorders in Pavia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 50 or older
- Assessment conducted using GPcog or ACE-III depending on the setting
- No prior diagnosis of cognitive decline
- Ability to understand the study objectives and sign informed consent
- Patients included in the Ricor-Dare Project or attending clinical visits at CDCD Fondazione Mondino Pavia or Lomellina
- Caregivers aged 18 or older providing informal care to family members with suspected or confirmed dementia
- Healthcare and social care professionals in Pavia and Vigevano participating in the project and consenting to assessments and training
You will not qualify if you...
- Age under 50
- Presence of a diagnosis of cognitive decline
- Limited knowledge of the Italian language
- Patients unable to understand the study aims or sign informed consent
- Caregivers under 18 years old
- Formal caregivers who receive payment for care
- Caregivers with limited knowledge of the Italian language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, Pavia, Italy, 27100
Actively Recruiting
Research Team
N
Nicola Allegri, PhD
CONTACT
A
Alessia Rosi, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here